| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the * Centre for Cellular and Molecular
Biology, Hyderabad, India; and the
Institute
of Reproductive Medicine, Salt Lake City, Kolkata, India.
| Correspondence to: Dr Kumarasamy Thangaraj, Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India (e-mail: thangs{at}ccmb.res.in). |
| Received for publication May 24, 2005; accepted for publication August 19, 2005. |
| Abstract |
|---|
|
|
|---|
Key words: Azoospermia, oligozoospermia, oligoteratozoospermia, spermatogenesis
The androgen sensitivity index (ASI) is the multiplication product of leutinizing hormone (LH) and testosterone level values. Elevated ASI has been suggested as an indication of androgen insensitivity because the impaired feedback regulatory mechanism of the gonadotropin-androgen axis leads to an elevation of LH and testosterone levels (Aiman et al, 1979; Hiort et al, 2000). It is a well-known fact that germ cells are nurtured by Sertoli cells for their differentiation into sperm, and Sertoli cells are in turn dependent upon Leydig cells for androgens. Although germ cells themselves do not express AR, they are indirectly dependent upon androgens and hence AR for their differentiation into sperm. Studies of a hypomorphic and conditional allele of the AR gene have uncovered a dual postmeiotic requirement for androgen receptor activity during male germ cell differentiation.
Observations in AR hypomorphic animals demonstrate that terminal differentiation of spermatids and their release from the seminiferous epithelium is AR dependent and maximally sensitive to AR depletion within the testis. Cell-specific disruption of AR in Sertoli cells of hypomorphic animals further shows that progression of late-round spermatids to elongating steps is sensitive to loss of Sertoli cell AR function (Holdcraft and Braun, 2004). Considering this, ARs appear to play a role in the final stages of sperm differentiation to attain elongated morphology, and hence point mutations in the AR gene are more likely to result in dysmorphic sperm (teratozoospermia or oligoteratozoospermia) rather than complete absence of sperm (azoospermia).
Although a few studies carried out on infertile men from other parts of the world found mutations in the AR gene (Wang et al, 1998; Ghadessy et al, 1999; Hiort et al, 2000; Yong et al, 2003), no such study has been conducted on Indian populations. Therefore, we undertook this study to test the hypothesis that AR mutations are more likely to cause oligoteratozoospermia than oligozoospermia or azoospermia and that elevated ASI values are an indication of AR mutations and to look at the overall contribution of AR mutations in male infertility among Indian populations.
| Materials and Methods |
|---|
|
|
|---|
|
Hormone Assays and Testicular Biopsy Studies![]()
Testosterone, leutinizing horomone (LH), and follicle stimulating hormone
(FSH) levels were measured for both patient and control groups by
radioimmunoassays. Absolute values of testosterone and LH were multiplied to
calculate the ASI (Table 1).
Testicular biopsy for azoospermic and oligozoospermic individuals was done
wherever it was possible. A small incision was made in both the testicles
under local anesthesia for taking the biopsies. Tissue sections were stained
with hematoxylin-eosin for histological examination. The processed tissue
sections were observed under an Axioplan 2 imaging system (Zieman, Zeiss,
Germany).
Genetic Analysis![]()
DNA was extracted from peripheral blood by a method described elsewhere
(Thangaraj et al, 2002).
Polymerase chain reaction primers covering the exon-intron splice junctions
for the AR gene (Table
2) were designed using GeneTool software and synthesized using a
394 DNA/RNA oligosynthesizer (Applied Biosystems, Foster City, Calif). All 8
exons of the AR gene were amplified and subjected to direct
sequencing using dideoxy chain terminator cycle sequencing protocol (BigDye
V3.1, Foster City, Calif) (Thangaraj et
al, 2003b) and ABI 3730 DNA Analyzer (Applied Biosystems). The
first exon, being large in size, was amplified with 4 overlapping pairs of
primers. Multiple alignment and sequence analysis was carried out using
Auto-Assembler software.
|
| Results |
|---|
|
|
|---|
|
Genetic Analysis of the AR Gene![]()
Sequences obtained from all 8 exons of the AR gene of all samples
were compared with the reference sequence, and no mutations were found in any
of the patients. Although CAG and GGN repeat motifs present in exon 1 of the
gene showed repeat length variation, they were within the normal range.
| Discussion |
|---|
|
|
|---|
It is known that FSH regulates AR expression in Sertoli cells (Blok et al, 1992), and most studies suggest that ARs are not present in germ cells (Bremner et al. 1994). Tesarik et al (1998) demonstrated that testosterone potentiates the effects of FSH in spermatogenesis by preventing Sertoli cell apoptosis, and hence spermatogenesis can proceed in the presence of only FSH without testosterone. Thus, mutations in the AR gene are more likely to cause low or defective sperm production (oligozoospermia, teratozoospermia, or oligoteratozoospermia) rather than the complete absence of sperm (azoospermia). Hiort et al (2000) supported this hypothesis on the basis of their finding of a mutation in the AR gene in 3 oligoteratozoospermic cases out of a total cohort of 180 patients from a German population. Accordingly, most of the studies on the AR gene have found mutations in oligozoospermia or oligoteratozoospermia (Yong et al, 2003) and not in azoospermia (Tincello et al, 1997), except 2 studies in which a mutation was found in azoospermia (Akin et al, 1991; Wang et al, 1998).
Our study suggests that mutations in the AR gene are less likely to cause azoospermia and oligozoospermia. However, the sample size of oligoteratozoospermia was not large enough to make firm conclusions about the role of the AR gene in oligoteratozoospermia. Earlier studies have proposed that an elevated ASI is an indication of androgen insensitivity and hence AR mutations (Aiman et al, 1979), but our study shows that none of the azoospermic and oligozoospermic cases having elevated ASI values possessed an AR mutation. On the basis of this observation, we would like to revise the above hypothesis and propose that an elevated ASI value may be an indication of androgen insensitivity and, hence, AR mutations in teratozoospermic or oligoteratozoospermic cases but not in azoospermic or oligozoospermic cases. The reasons we did not find mutations in ARs in any of the oligoteratozoospermic cases may be because of the comparatively smaller number of these samples and because none of these samples had an elevated ASI value. However, the possibility of mutation in AR coactivators in any of these categories of infertile samples cannot be denied. A better understanding of the genetic makeup of different ethnic populations and the hormonal requirements of adult spermatogenesis is needed for proper diagnosis and development of rational treatments for male infertility and for designing contraceptive strategies.
| References |
|---|
|
|
|---|
Akin JW, Behzadian A, Tho SP, McDonough PG. Evidence for a partial deletion in the androgen receptor gene in a phenotypic male with azoospermia. Am J Obstet Gynecol. 1991; 165: 1891 -1894.[Medline]
Akin JW, Behzadian A, Tho SP, McDonough PG. Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein. Endocrinology. 1992; 131: 1343 -1349.[Abstract]
Bremner WJ, Millar MR, Sharpe RM, Saunders PT. Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology. 1994; 135: 1227 -1234.[Abstract]
Ghadessy FJ, Lim J, Abdullah AA, Panet-Raymond V, Choo CK, Lumbroso R, Tut TG, Gottlieb B, Pinsky L, Trifiro MA, Yong EL. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J Clin Invest. 1999; 103: 1517 -1525.[Medline]
Gottlieb B. The androgen receptor gene mutation database. World Wide Web server. April 4, 2005. Available at: http://www.mcgill.ca/androgendb. Accessed October 10, 2005.
Gottlieb B, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. Update of the androgen receptor gene mutations database. Hum Mutat. 1999;14: 103 -114.[CrossRef][Medline]
Hiort O, Holterhus PM, Horter T, Schulze W, Kremke B, Bals-Pratsch
M, Sinnecker GH, Kruse K. Significance of mutations in the androgen receptor
gene in males with idiopathic infertility. J Clin Endocrinol
Metab. 2000;85: 2810
-2815.
Holdcraft RW, Braun RE. Androgen receptor function is required in
Sertoli cells for the terminal differentiation of haploid spermatids.
Development. 2004; 131: 459
-467.
Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson
EM. Cloning of human androgen receptor complementary DNA and localization to
the X chromosome. Science. 1988; 240: 327
-330.
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrinol Rev. 1995; 16: 271 -321.[CrossRef][Medline]
Tesarik J, Guido M, Mendoza C, Greco E. Human spermatogenesis in
vitro: respective effects of follicle-stimulating hormone and testosterone on
meiosis, spermiogenesis, and Sertoli cell apoptosis. J Clin
Endocrinol Metab. 1998;83: 4467
-4473.
Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L.
CAG repeat expansion in the androgen receptor gene is not associated with male
infertility in Indian populations. J Androl. 2002; 23: 815
-818.
Thangaraj K, Gupta NJ, Pavani K, Reddy AG, Subramainan S, Rani DS,
Ghosh B, Chakravarty B, Singh L. Y chromosome deletions in azoospermic men in
India. J Androl. 2003a; 24: 588
-597.
Thangaraj K, Singh L, Reddy AG, Rao VR, Sehgal SC, Underhill PA, Pierson M, Frame IG, Hagelberg E. Genetic affinities of the Andaman Islanders, a vanishing human population. Curr Biol. 2003b; 13: 86 -93.[CrossRef][Medline]
Tincello DG, Saunders PT, Hargreave TB. Preliminary investigations
on androgen receptor gene mutations in infertile men. Mol Hum
Reprod. 1997;3: 941
-943.
Wang Q, Ghadessy FJ, Trounson A, de Kretser D, McLachlan R, Ng SC,
Yong EL. Azoospermia associated with a mutation in the ligand-binding domain
of an androgen receptor displaying normal ligand binding, but defective
trans-activation. J Clin Endocrinol Metab. 1998; 83: 4303
-4309.
Yong EL, Ghadessy F, Wang Q, Mifsud A, Ng SC. Androgen receptor transactivation domain and control of spermatogenesis. Rev Reprod. 1998;3; 141 -144.[Abstract]
Yong EL, Loy CJ, Sim KS. Androgen receptor gene and male
infertility. Hum Reprod Update. 2003; 9: 1
-7.
This article has been cited by other articles:
![]() |
C. A. Davis-Dao, E. D. Tuazon, R. Z. Sokol, and V. K. Cortessis Male Infertility and Variation in CAG Repeat Length in the Androgen Receptor Gene: A Meta-analysis J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4319 - 4326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajender, V. Rajani, N. J. Gupta, B. Chakravarty, L. Singh, and K. Thangaraj No Association of Androgen Receptor GGN Repeat Length Polymorphism With Infertility in Indian Men J Androl, November 1, 2006; 27(6): 785 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, P. K. Shastry, A. A. Rasalkar, L. Singh, and K. Thangaraj A Novel Androgen Receptor Mutation Resulting in Complete Androgen Insensitivity Syndrome and Bilateral Leydig Cell Hyperplasia J Androl, July 1, 2006; 27(4): 510 - 516. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |